Journal scan

Blood test could predict best lung cancer treatment

A blood test could predict how well patients with small-cell lung cancer will respond to treatment, say researchers from the University of Manchester. 
cancer cells

A blood test could predict how well patients with small-cell lung cancer will respond to treatment, say researchers from the University of Manchester.

They isolated tumour cells that had broken away from the main cancer – known as circulating tumour cells – from the blood of 31 patients with small-cell lung cancer (SCLC).

Starting point

When the cells were analysed, the researchers found that patterns of genetic faults measured before treatment were linked to how well and how long a patient might respond to chemotherapy.

Lead researcher Caroline Dive, based at the Cancer Research UK Manchester Institute, said: ‘Unfortunately, we have very few treatment options for patients with SCLC, and none at all for those whose cancer is resistant to chemotherapy.

‘By

...

Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Nursing Standard
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?

Jobs